In prostate cancer, the knockdown of LAMTOR4 resulted in downregulation of beta-catenin, a key player in cell adhesion and gene transcription, and the upregulation of phospho-PTEN, a phosphorylated form of the tumor suppressor PTEN observed in our experiments. Here, PTEN is linked to prostate cancer.